approval
saveMORPHINE SULFATE — FDA approval
December 22, 2025updated 5mo ago
community read0 votes
Sponsor: TEVA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025
- approvalACTIQ (FENTANYL CITRATE) — FDA approvalDec 22, 2025
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalDec 22, 2025
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025
🐶 often sniffed alongside
top 8- tagRecall26 co-mentions · 19 sources
- tagDrug Shortage9 co-mentions · 9 sources
- drugprazosin hydrochloride6 co-mentions · 3 sources
- drugISOTRETINOIN4 co-mentions · 2 sources
- drugAbsorica4 co-mentions · 2 sources
- drugmetoprolol succinate SR4 co-mentions · 4 sources
- drugmetoprolol succinate ER4 co-mentions · 4 sources
- drugZENATANE4 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that